Efficacy and Safety of the BRAF Inhibitor Vemurafenib in Hairy Cell Leukemia Patients Refractory to or Relapsed after Purine Analogs: A Phase-2 Italian Clinical Trial
Year: 2014
Type: article
Study design: Clinical Trial
Source: Blood
Authors: Enrico Tiacci, Luca De Carolis, Pier Luigi Zinzani, Alessandro Pulsoni, Francesco Zaja, Michele Cimminiello, Achille Ambrosetti, Davide Rossi, Giovanna Motta, Marzia Varettoni, Vincenzo Fraticelli, Angelo Michele Carella, Antonella Anastasia, Pietro Leoni, Alessandro Rambaldi, Stefano Aldo Pileri, Robin Foà, Brunangelo Falini
Institutions: University of Perugia, University of Bologna, Sapienza University of Rome, University of Udine, Azienda sanitaria universitaria Friuli Centrale, Ospedale San Carlo, University of Verona, Università degli Studi del Piemonte Orientale “Amedeo Avogadro”, Ferrarotto Hospital, Policlinico San Matteo Fondazione, Ospedale Policlinico San Martino, Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia, Azienda Ospedaliero-Universitaria delle Marche, Ospedale Papa Giovanni XXIII
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W768647209